Harnessing Nanoparticles for Immunomodulation and Vaccines
The first successful use of nanoparticles (NPs) for vaccination was reported almost 40 years ago with a virus-like particle-based vaccine against Hepatitis B. Since then, the term NP has been expanded to accommodate a large number of novel nano-sized particles engineered from a range of materials. T...
| Autors principals: | , , |
|---|---|
| Format: | Article |
| Idioma: | English |
| Publicat: |
MDPI AG
2017-02-01
|
| Col·lecció: | Vaccines |
| Matèries: | |
| Accés en línia: | http://www.mdpi.com/2076-393X/5/1/6 |